13.50
-0.66 (-4.66%)
-0.66 (-4.66%)
Upgrade to Real-Time
Regular Market
Low
11.50
High
37.8603
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Oncorus Inc | ONCR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.66 | -4.66% | 13.50 | 14:25:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 14.20 | 13.00 | 14.25 | 14.16 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 13.40 | 13.54 | 0.14 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,324 | 173,788 | $ 13.57 | $ 2,357,764 | 113,185 | 11.50 - 37.8603 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:28:09 | 5 | $ 13.53 | USD |
Oncorus Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 305.32M | 22.62M | 14.90M | $ - | $ - | -3.35 | -7.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 10.34M | 1.80% |
Oncorus News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONCR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.03 | 14.63 | 13.00 | 13.94 | 113,801 | -0.53 | -3.78% |
| 1 Month | 15.78 | 16.34 | 11.50 | 13.69 | 194,832 | -2.28 | -14.45% |
| 3 Months | 26.09 | 26.766 | 11.50 | 16.02 | 188,645 | -12.59 | -48.26% |
| 6 Months | 17.29 | 37.8603 | 11.50 | 20.20 | 139,656 | -3.79 | -21.92% |
| 1 Year | 15.50 | 37.8603 | 11.50 | 19.76 | 146,241 | -2.00 | -12.9% |
| 3 Years | 15.50 | 37.8603 | 11.50 | 19.76 | 146,241 | -2.00 | -12.9% |
| 5 Years | 15.50 | 37.8603 | 11.50 | 19.76 | 146,241 | -2.00 | -12.9% |
Oncorus Description
| Oncorus Inc is a clinical stage biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients. The company is in the process of developing intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors. |
